Phase III randomized, double-blind, active-controlled study of momelotinib versus ruxolitinib in patients with myelofibrosis.

被引：0
作者：
Winton, Elliott F.
Devos, Timothy
Oh, Stephen T.
Platzbecker, Uwe
Wadleigh, Martha
Jun, Susie
Lee, Peter
Deng, Wei
Gupta, Vikas
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Univ Ziekenhuizen Leuven UZ Leuven, Leuven, Belgium
[3] Washington Univ, St Louis, MO USA
[4] TUD, Univ Hosp Carl Gustav Carus, Dresden, Germany
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Gilead Sci Inc, Foster City, CA USA
[7] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS7101
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase 2 study of ruxolitinib in combination with 5-azacitidine in patients with myelofibrosis.
    Masarova, Lucia
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Jabbour, Elias
    Bose, Prithviraj
    Ohanian, Maro
    Zhou, Lingsha
    Pierce, Sherry
    Gergis, Romany
    Borthakur, Gautam
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    Daver, Naval Guastad
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis
    Yan Xue
    Xianghong Qin
    Liya Zhou
    Sanren Lin
    Ling Wang
    Haitang Hu
    Jielai Xia
    Clinical Drug Investigation, 2016, 36 : 985 - 992
  • [33] Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis
    Oh, Jung-Hwan
    Kim, Hyun-Soo
    Cheung, Dae Young
    Lee, Hang Lak
    Lee, Dong Ho
    Kim, Gwang Ha
    Choi, Suck Chei
    Cho, Yu Kyung
    Chung, Woo Chul
    Kim, Ji Won
    Yu, Eunju
    Kwon, Hyesoo
    Kim, Jun
    Kim, John
    Jung, Hwoon-Yong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (02) : 353 - 361
  • [34] Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study
    Hale, ME
    Dvergsten, C
    Gimbel, J
    JOURNAL OF PAIN, 2005, 6 (01) : 21 - 28
  • [35] Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study (vol 401, pg 269, 2023)
    Allinson, James Peter
    Chaturvedi, Nishi
    Wong, Andrew
    LANCET, 2023, 402 (10418) : 2196 - 2196
  • [36] Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study
    Blanco, Francisco J.
    Moericke, Ruediger
    Dokoupilova, Eva
    Codding, Christine
    Neal, Jeffrey
    Andersson, Mats
    Rohrer, Susanne
    Richards, Hanno
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (06) : 1144 - 1153
  • [37] ASCEND-TD: A Randomized, Double-Blind, Active-Controlled Study of Daprodustat Administered Three Times Weekly in Hemodialysis Patients
    Coyne, Daniel W.
    Singh, Ajay K.
    Lopes, Renato D.
    Bailey, Christine K.
    Dimino, Tara L.
    Huang, Chun
    Connaire, Jeffrey J.
    Rastogi, Anjay
    Kim, Sung Gyun
    Orias, Marcelo
    Shah, Sapna
    Patel, Vickas
    Cobitz, Alexander R.
    Wanner, Christoph
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 191 - 191
  • [38] Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study (vol 401, pg 269, 2023)
    Verstovsek, S.
    Gerds, A. T.
    Vannucchi, A. M.
    LANCET, 2023, 401 (10386) : 1426 - 1426
  • [39] Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: A randomized, double-blind, active-controlled trial
    Tyring, Stephen K.
    Plunkett, Stephanie
    Scribner, Anita R.
    Broker, Robert E.
    Herrod, John N.
    Handke, Lane T.
    Wise, John M.
    Martin, Paul A.
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (08) : 1224 - 1232
  • [40] Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical Study
    Lee, Han Cheol
    Lee, Sang-Rok
    Han, Kyoo-Rok
    Yu, Cheol-Woong
    Park, Chang-Gyu
    Ahn, Young-Keun
    Jin, Han-Young
    Kim, Dong-Woon
    Cho, Deok-Kyu
    Choi, SeungHyuk
    Kim, Sang-Hyun
    Chang, Ki-yuk
    Lee, Seunghwan
    Pyun, Wookbum
    Lee, Nam-ho
    Kang, Woongchol
    Hong, Bum-Kee
    Cho, Byung-Ryul
    Chae, In-Ho
    Shin, Joon-Han
    Chun, Kookjin
    Kim, Doo-il
    Lee, Jae-Won
    Kim, Young -Jae
    Choi, Donghoon
    CLINICAL THERAPEUTICS, 2016, 38 (03) : 557 - 573
12345